Page 153 - Cascade_Biocatalysis_Integrating_Stereoselective_and_Environmentally_Friendly_Reactions
P. 153

References  129

                   CYP27B1 responsible for binding of  79. Wichmann, R., Wandrey, C.,
                   25-hydroxyvitamin D3 whose mutation  Buckmann, A.F., and Kula, M.R. (2000)
                   causes vitamin D-dependent rick-  Continuous enzymatic transformation
                   ets type 1. J. Biol. Chem., 280 (34),  in an enzyme membrane reactor with
                   30511–30516.                    simultaneous NAD(H) regeneration.
                71. Prosser, D.E. and Jones, G. (2004)  Reprinted from Biotechnology and Bio-
                   Enzymes involved in the activation  engineering, Vol. XXIII, No. 12, Pages
                   and inactivation of vitamin D. Trends  2789–2802 (1981). Biotechnol. Bioeng.,
                   Biochem. Sci., 29 (12), 664–673.  67 (6), 791–804.
                72. Guo, Y.D., Strugnell, S., Back, D.W.,  80. Fulco, A.J. (1991) P450BM-3 and other
                   and Jones, G. (1993) Transfected  inducible bacterial P450 cytochromes:
                   human liver cytochrome P-450 hydrox-  biochemistry and regulation. Annu.
                   ylates vitamin D analogs at different  Rev. Pharmacol. Toxicol., 31, 177–203.
                   side-chain positions. Proc. Natl. Acad.  81. Narhi, L.O. and Fulco, A.J. (1986)
                   Sci. U.S.A., 90 (18), 8668–8672.  Characterization of a catalytically self-
                73. Kitanaka, S., Takeyama, K., Murayama,
                                                   sufficient 119,000-dalton cytochrome
                   A., Sato, T., Okumura, K., Nogami, M.,
                                                   P-450 monooxygenase induced by bar-
                   Hasegawa, Y., Niimi, H., Yanagisawa,
                                                   biturates in Bacillus megaterium. J. Biol.
                   J., Tanaka, T., and Kato, S. (1998)  Chem., 261 (16), 7160–7169.
                   Inactivating mutations in the 25-  82. Ahmed, F.,Al-Mutairi, E.H.,Avery,
                   hydroxyvitamin D3 1alpha-hydroxylase  K.L., Cullis, P.M., Primrose, W.U.,
                   gene in patients with pseudovitamin  Roberts, G.C.K., and Willis, C.L. (1999)
                   D-deficiency rickets. N. Engl. J. Med.,
                                                   An unusual matrix of stereocom-
                   338 (10), 653–661.
                                                   plementarity in the hydroxylation of
                74. Fu, G.K., Lin, D., Zhang, M.Y., Bikle,
                                                   monohydroxy fatty acids catalysed by
                   D.D., Shackleton, C.H., Miller, W.L.,  cytochrome P-450 from Bacillus mega-
                   and Portale, A.A. (1997) Cloning of  terium with potential application in
                   human 25-hydroxyvitamin D-1 alpha-  biotransformations. Chem. Commun.
                   hydroxylase and mutations causing  (Camb.), 20, 2049–2050.
                   vitamin D-dependent rickets type 1.
                                                83. Falck, J.R., Reddy, Y.K., Haines, D.C.,
                   Mol. Endocrinol., 11 (13), 1961–1970.
                                                   Reddy, K.M., Krishna, U.M., Graham,
                75. Sawada, N., Sakaki, T., Yoneda, S.,
                                                   S., Murry, B., and Peterson, J.A. (2001)
                   Kusudo, T., Shinkyo, R., Ohta, M., and
                                                   Practical, enantiospecific synthesis of
                   Inouye, K. (2004) Conversion of vita-
                                                   14,15-EET and leukotoxin B (vernolic
                   min D3 to 1alpha,25-dihydroxyvitamin
                                                   acid). Tetrahedron Lett., 42, 4131–4133.
                   D3 by Streptomyces griseolus
                                                84. Kubo, T., Peters, M.W., Meinhold, P.,
                   cytochrome P450SU-1. Biochem. Bio-
                                                   and Arnold, F.H. (2006) Enantioselec-
                   phys.Res.Commun., 320 (1), 156–164.
                                                   tive epoxidation of terminal alkenes
                76. Sugimoto, H., Shinkyo, R., Hayashi, K.,
                   Yoneda, S., Yamada, M., Kamakura,  to (R)- and (S)-epoxides by engineered
                   M., Ikushiro, S., Shiro, Y., and  cytochromes P450 BM-3. Chemistry, 12
                   Sakaki, T. (2008) Crystal structure  (4), 1216–1220.
                   of CYP105A1 (P450SU-1) in complex  85. Al-Kassim, L.S. and Tsai, C.S. (1990)
                   with 1alpha,25-dihydroxyvitamin D3.  Studies of NADP(+)-preferred sec-
                   Biochemistry, 47 (13), 4017–4027.  ondary alcohol dehydrogenase from
                77. Chenault, H.K., Simon, E.S., and  Thermoanaerobium brockii. Biochem.
                   Whitesides, G.M. (1988) Cofactor  Cell Biol., 68 (6), 907–913.
                   regeneration for enzyme-catalysed syn-  86. Seelbach, K., Riebel, B., Hummel, W.,
                   thesis. Biotechnol. Genet. Eng. Rev., 6,  Kula, M.R., Tishkov, V., Egorov, A.M.,
                   221–270.                        Wandrey, C., and Kragl, U. (1996) A
                78. Wichmann, R. and Vasic-Racki, D.  novel, efficient regenerating method
                   (2005) Cofactor regeneration at the lab  of NADPH using a new formate dehy-
                   scale. Adv. Biochem. Eng. Biotechnol.,  drogenase. Tetrahedron Lett., 37 (9),
                   92, 225–260.                    1377–1380.
   148   149   150   151   152   153   154   155   156   157   158